Physician

Cheryl Janene Gustafson, MD

According to 2025 Medicare claims, Cheryl Gustafson, MD (NPI: 1083840565) practices dermatology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SILVER FALLS DERMATOLOGY, LLC (NPI: 1134375421; TIN: 262636087) and primary practice location at 98026-7536.

Gustafson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 774 traditional Medicare patients, billed 3,065 HCPCS/CPT codes, and received $222,709 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,045 prescription claims across 431 beneficiaries totaling $322,219 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 10 records totaling $245. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,429 to $322,219. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$303K2016 Medicare payment: $263,411 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $208,560 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $267,446 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $302,555 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $192,714 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $218,294 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $286,924 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $248,624 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $222,709 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162831,024$263,411
20174111,519$208,560
20184732,892$267,446
20195643,612$302,555
20204992,164$192,714
20216812,941$218,294
20227483,653$286,924
20236903,979$248,624
20247743,065$222,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$161K$322K2015 Drug cost: $4,429 (USD; Tot_Drug_Cst)2016 Drug cost: $2,246 (USD; Tot_Drug_Cst)2017 Drug cost: $48,733 (USD; Tot_Drug_Cst)2018 Drug cost: $88,965 (USD; Tot_Drug_Cst)2019 Drug cost: $160,699 (USD; Tot_Drug_Cst)2020 Drug cost: $165,977 (USD; Tot_Drug_Cst)2021 Drug cost: $173,657 (USD; Tot_Drug_Cst)2022 Drug cost: $265,090 (USD; Tot_Drug_Cst)2023 Drug cost: $297,020 (USD; Tot_Drug_Cst)2024 Drug cost: $322,219 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152671$4,429
2016180257$2,246
2017198294$48,733
2018241525$88,965
2019230539$160,699
2020246613$165,977
2021305727$173,657
2022370868$265,090
2023360917$297,020
20244311,045$322,219

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more256329$86
17110Destruction of skin growth, 1-14 growths192220$82
11102Biopsy of related skin growth, first growth118133$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more453569$60
17000Destruction of precancer skin growth, 1 growth168193$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab14392$126,491
Betamethasone DipropionateBetamethasone Dipropionate982,726$4,356
MetronidazoleMetronidazole581,935$2,681
Clobetasol PropionateClobetasol Propionate602,146$2,457
KetoconazoleKetoconazole1154,019$1,594

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$245Incyte Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Cheryl Janene Gustafson, MD?

Tedicare shows public-source Medicare data for Cheryl Janene Gustafson, MD (NPI 1083840565), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cheryl Janene Gustafson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cheryl Janene Gustafson, MD?

Cheryl Janene Gustafson, MD is linked to SILVER FALLS DERMATOLOGY, LLC (billing NPI 1134375421) in the available physician profile data.

Does Cheryl Janene Gustafson, MD have Open Payments data?

Cheryl Janene Gustafson, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.